Skip to main content
SLAS Europe 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Short Course
Short Course
On Demand
On Demand

  1. Home

  • Wednesday, May 24th
    11:30 – 13:00 CET
    Micro-environment and complexity
    Room/Location: 304 (Level -1)
    Samy Gobaa, PhD – Institut Pasteur
    Biology Unveiled
  • Wednesday, May 24th
    11:30 – 12:00 CET
    Patient-derived scaffolds - a model for identifying cancer promoting properties of the tumor microenvironment relevant for cancer drug design and treatment prediction
    Room/Location: 304 (Level -1)
    Elena Garre, PhD (she/her/hers) – University of Gothenburg, Sahlgrenska Academy
    Biology Unveiled
  • Wednesday, May 24th
    12:00 – 12:30 CET
    Standardized patient-derived organoids predict clinical toxicity: A case study in immuno-oncology
    Room/Location: 304 (Level -1)
    Biology Unveiled
  • Wednesday, May 24th
    12:30 – 13:00 CET
    Automation-compatible phenotypic high-content screening using patient-derived neuronal precursor cells identifies small molecules targeting Leigh syndrome
    Room/Location: 304 (Level -1)
    Annika Wittich, MSc (she/her/hers) – Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, ScreeningPort, 22525 Hamburg, Germany
    Biology Unveiled
  • Wednesday, May 24th
    14:30 – 16:00 CET
    Innovative Strategies for Target Identification
    Room/Location: 304 (Level -1)
    Biology Unveiled
  • Wednesday, May 24th
    14:30 – 15:00 CET
    The application of arrayed CRISPR screening for target identification in primary cells
    Room/Location: 304 (Level -1)
    Biology Unveiled
  • Wednesday, May 24th
    15:00 – 15:30 CET
    High-throughput functional genomics using CRISPR base editing in cancer cells
    Room/Location: 304 (Level -1)
    Matthew Coelho, Dr. – Wellcome Sanger Institute
    Biology Unveiled
  • Wednesday, May 24th
    15:30 – 16:00 CET
    AI-augmented mechanistic target identification at BenevolentAI
    Room/Location: 304 (Level -1)
    Biology Unveiled
  • Thursday, May 25th
    10:30 – 12:30 CET
    Advanced Disease Models
    Room/Location: 304 (Level -1)
    Guillaume Dumenil, Dr – Institut Pasteur
    Biology Unveiled
  • Thursday, May 25th
    10:30 – 11:00 CET
    Engineering vessels-on-a-chip to study human vascular diseases
    Room/Location: 304 (Level -1)
    Guillaume Dumenil, Dr – Institut Pasteur
    Biology Unveiled
  • Thursday, May 25th
    11:00 – 11:30 CET
    Functional and morphological characterization of healthy and epilepsy-related 3D neurospheres assembled using iPSC-derived neurons and astrocytes
    Room/Location: 304 (Level -1)
    Biology Unveiled
  • Thursday, May 25th
    11:30 – 12:00 CET
    Droplet Microarray chip: towards functional personalized oncology
    Room/Location: 304 (Level -1)
    Anna Popova, PhD – Karlsruhe Institute of technology
    Biology Unveiled
  • Thursday, May 25th
    12:00 – 12:30 CET
    Microfluidic palette for in vitro modelling of human neuronal circuit.
    Room/Location: 304 (Level -1)
    Quyen Do, Miss – University of Oxford
    Biology Unveiled
  • Thursday, May 25th
    14:30 – 16:00 CET
    Precision medicine in the future
    Room/Location: 304 (Level -1)
    Anders Staahlberg (he/him/his) – University of Gothenburg
    Biology Unveiled
  • Thursday, May 25th
    14:30 – 15:00 CET
    Personalized biomarker analysis in liquid biopsies enable precision medicine
    Room/Location: 304 (Level -1)
    Anders Staahlberg (he/him/his) – University of Gothenburg
    Biology Unveiled
  • Thursday, May 25th
    15:00 – 15:30 CET
    Bioengineering organoid fate and morphogenesis
    Room/Location: 304 (Level -1)
    Adrian Ranga, PhD – KU Leuven
    Biology Unveiled
  • Thursday, May 25th
    15:30 – 16:00 CET
    Integrated arrayed CRISPR pipeline to mechanistically annotate sensitisation hits to PARP inhibitors
    Room/Location: 304 (Level -1)
    Grainne Gernon, PhD – AstraZeneca
    Biology Unveiled